ReviewJCO precision oncology2025

Using Dose-Escalation and -Expansion Cohort Study as Pivotal Trial for Targeted Anticancer Drug Approval.

Yafang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.